Literature DB >> 17456832

An evidence-based update on nonsteroidal anti-inflammatory drugs.

C K S Ong1, P Lirk, C H Tan, R A Seymour.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs), including both traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. NSAIDs are a necessary choice in pain management because of the integrated role of the COX pathway in the generation of inflammation and in the biochemical recognition of pain. This group of drugs has recently come under scrutiny because of recent focus in the literature on the various adverse effects that can occur when applying NSAIDs. This review will provide an educational update on the current evidence of the efficacy and adverse effects of NSAIDs. It aims to answer the following questions: (1) are there clinically important differences in the efficacy and safety between the different NSAIDs, (2) if there are differences, which are the ones that are more effective and associated with fewer adverse effects, and (3) which are the effective therapeutic approaches that could reduce the adverse effects of NSAIDs. Finally, an algorithm is proposed which delineates a general decision-making tree to select the most appropriate analgesic for an individual patient based on the evidence reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456832      PMCID: PMC1855338          DOI: 10.3121/cmr.2007.698

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  107 in total

1.  Parecoxib, valdecoxib, and cardiovascular risk.

Authors:  Curt D Furberg; Bruce M Psaty; Garret A FitzGerald
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

2.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

3.  Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers.

Authors:  Byron Cryer; Roger G Berlin; Stephen A Cooper; Ching Hsu; Suman Wason
Journal:  Clin Ther       Date:  2005-02       Impact factor: 3.393

4.  Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials.

Authors:  Nadia Elia; Christopher Lysakowski; Martin R Tramèr
Journal:  Anesthesiology       Date:  2005-12       Impact factor: 7.892

5.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

Authors:  J D Bradley; K D Brandt; B P Katz; L A Kalasinski; S I Ryan
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

6.  Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.

Authors:  M Koch; A Dezi; F Ferrario; I Capurso
Journal:  Arch Intern Med       Date:  1996-11-11

Review 7.  Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe?

Authors:  J L Wallace; B K Reuter; W McKnight; A Bak
Journal:  J Clin Gastroenterol       Date:  1998       Impact factor: 3.062

8.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors:  R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal:  BMJ       Date:  1988-10-22

9.  Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.

Authors:  A J Kivitz; S Nayiager; T Schimansky; A Gimona; H J Thurston; C Hawkey
Journal:  Aliment Pharmacol Ther       Date:  2004-06-01       Impact factor: 8.171

Review 10.  Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jayne E Edwards; Henry J McQuay; Andrew R Moore
Journal:  Pain       Date:  2004-10       Impact factor: 6.961

View more
  105 in total

1.  Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study.

Authors:  Kavita Gajria; Mark Kosinski; Jeff Schein; Shane Kavanagh; Dominique Dubois
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

2.  Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.

Authors:  Wen-Nan Huang; Tim K Tso
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

3.  Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study.

Authors:  Luis Hermenegildo Martin Arias; Antonio Martin Gonzalez; Rosario Sanz Fadrique; Esther Salgueiro; Maria Sainz
Journal:  Int J Clin Pharm       Date:  2018-07-31

4.  Indomethacin impairs mitochondrial dynamics by activating the PKCζ-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells.

Authors:  Somnath Mazumder; Rudranil De; Subhashis Debsharma; Samik Bindu; Pallab Maity; Souvik Sarkar; Shubhra Jyoti Saha; Asim Azhar Siddiqui; Chinmoy Banerjee; Shiladitya Nag; Debanjan Saha; Saikat Pramanik; Kalyan Mitra; Uday Bandyopadhyay
Journal:  J Biol Chem       Date:  2019-04-02       Impact factor: 5.157

5.  Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.

Authors:  Komba Thomas; Terry W Moody; Robert T Jensen; Jason Tong; Cassie L Rayner; Nigel L Barnett; Kathryn E Fairfull-Smith; Lisa A Ridnour; David A Wink; Steven E Bottle
Journal:  Eur J Med Chem       Date:  2018-01-31       Impact factor: 6.514

6.  Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts.

Authors:  Rajeshwary Ghosh; Sumanta K Goswami; Luis Felipe B B Feitoza; Bruce Hammock; Aldrin V Gomes
Journal:  Int J Cardiol       Date:  2016-08-13       Impact factor: 4.164

Review 7.  Effect of Sodium Valproate and Docosahexaenoic Acid on Pain in Rats.

Authors:  Sushil Kiran Kunder; Laxminarayana Kurady Bairy; Avinash Arivazhahan
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Comparison of the anti-inflammatory effect of dexamethasone and ketorolac in the extractions of third molars.

Authors:  Janayna Gomes Paiva-Oliveira; Paulo Roberto Haidamus Oliveira Bastos; Elenir R J Cury Pontes; Júlio César Leite da Silva; Jéssica Andréa Berto Delgado; Nelson Talatoci Oshiro-Filho
Journal:  Oral Maxillofac Surg       Date:  2015-11-16

9.  A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis.

Authors:  Stephen P Myers; Joan O'Connor; J Helen Fitton; Lyndon Brooks; Margaret Rolfe; Paul Connellan; Hans Wohlmuth; Phil A Cheras; Carol Morris
Journal:  Biologics       Date:  2010-03-24

10.  Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies.

Authors:  Włodzimierz Matysiak; Barbara Jodłowska-Jedrych
Journal:  Protoplasma       Date:  2010-08-19       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.